Insights

Gathering insights about Priothera SAS…

Similar companies to Priothera SAS

Priothera SAS Tech Stack

Priothera SAS uses 8 technology products and services including MySQL, oEmbed, Apple iCloud Mail, and more. Explore Priothera SAS's tech stack below.

MySQL
Database
oEmbed
Dev Tools
Apple iCloud Mail
Email
Google Fonts API
Font Scripts
Slick
Javascript Libraries
Isotope
Javascript Libraries
jQuery
Javascript Libraries
Google Tag Manager
Tag Management

Media & News

Priothera Limited receives financing of $2M in i-Nov funding.
Priothera secures EUR1.7 million i-Nov funding by Bpifrance for rare blood cancer clinical program.
Jun 24, 2025 | www.fh-partners.com
bpifrance.com invests into Priothera Limited $2M in i-Nov funding.
Priothera secures EUR1.7 million i-Nov funding by Bpifrance for rare blood cancer clinical program.
Jun 24, 2025 | www.fh-partners.com
Priothera Limited hired Hans Menssen as Board of Directors on Jun 3rd '25.
Saint-Louis, France and Dublin, Ireland - 3rd June 2025- Priothera Ltd., a late-stage biopharma company pioneering the development of mocravimod, a novel oral sphingosine 1 phosphate (S1P) receptor modulator, to treat hematologic malignancies, today announced the appointment of Dr. Hans Menssen, MD, PhD, BBA, to its Board of Directors.
Jun 03, 2025 | www.manilatimes.net
Priothera Limited hired Jens Hasskarl as Chief Medical Officer on May 6th '25.
Priothera today announced the appointment of Jens Hasskarl, as its chief medical officer (CMO).
May 06, 2025 | www.thepharmaletter.com
EUROAPI UK Ltd partnered with Priothera Limited on Jun 18th '24.
* EUROAPI and Priothera, a biotechnology company specializing in the treatment of hematological malignancies and the improvement of CAR-T cell therapies, have signed a 5-year CDMO agreement
Jun 18, 2024 | www.euroapi.com
Priothera Limited attends event 2024 American Society of Hematology (ASH) Annual Meeting.
Priothera to present Trial in Progress poster for mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting.
Jun 01, 2024 | priothera.com
Priothera Limited partnered with EIB on Feb 23rd '22.
Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator drug, mocravimod, today announces that it has entered a Loan Agreement of €17.5 million with the European Investment Bank (EIB).
Feb 23, 2022 | finance.yahoo.com

Priothera SAS's Email Address Formats

Priothera SAS uses at least 1 format(s):

Priothera SAS Email Formats	Example	Percentage
First.Last@priothera.com	John.Doe@priothera.com	100%

Frequently Asked Questions

Where is Priothera SAS's headquarters located?

Priothera SAS's main headquarters is located at 57 Avenue du Général de Gaulle Port-saint-louis-du-rhône, Provence-alpes-côte D'azur 68300 France. The company has employees across 2 continents, including EuropeNorth America.

What is Priothera SAS's official website and social media links?

Priothera SAS's official website is priothera.com and has social profiles on LinkedIn Crunchbase.

What is Priothera SAS's SIC code NAICS code?

Priothera SAS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Priothera SAS have currently?

As of April 2026, Priothera SAS has approximately 26 employees across 2 continents, including EuropeNorth America. Key team members include Chief Medical Officer: J. H.Chief Operating And Scientific Officer: S. O.Chief Business Officer: P. M. L.. Explore Priothera SAS's employee directory with LeadIQ.

What industry does Priothera SAS belong to?

Priothera SAS operates in the Biotechnology Research industry.

What technology does Priothera SAS use?

Priothera SAS's tech stack includes MySQLoEmbedApple iCloud MailGoogle Fonts APISlickIsotopejQueryGoogle Tag Manager.

What is Priothera SAS's email format?

Priothera SAS's email format typically follows the pattern of First.Last@priothera.com. Find more Priothera SAS email formats with LeadIQ.

How much funding has Priothera SAS raised to date?

As of April 2026, Priothera SAS has raised $2M in funding. The last funding round occurred on Jun 24, 2025 for $2M.

When was Priothera SAS founded?

Priothera SAS was founded in 2020.

Priothera SAS

Q: What is Priothera SAS's official website and social media links?

Priothera SAS's official website is priothera.com. Priothera SAS has social profiles on LinkedIn.

Q: How many employees does Priothera SAS have currently?

Priothera SAS has approximately 26 employees.

Q: What technology does Priothera SAS use?

Priothera SAS's tech stack includes Magnific Popup, Font Awesome, RSS, Microsoft 365, WordPress.

Q: What is Priothera SAS's NAICS code?

Priothera SAS's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchProvence-alpes-côte D'azur, France11-50 Employees

Priothera SAS is a France-based biotechnology company focused on hematologic cancers. It is developing an immune modulator designed to increase the curative potential of allogeneic hematopoietic stem cell transplantation, with the aim of improving patient outcomes.

Its work targets clinicians and patients involved in HSCT for hematologic malignancies. The company is based in Port-saint-louis-du-rhône in the Provence-Alpes-Côte d'Azur region, and in 2024 established a five-year CDMO partnership with EUROAPI UK Ltd to support its development and manufacturing efforts.

Company Overview

Headquarters: 57 Avenue du Général de Gaulle Port-saint-louis-du-rhône, Provence-alpes-côte D'azur 68300 France
Website: priothera.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2020
Employees: 11-50

Media & News

Funding & Financials

$2M
Priothera SAS has raised a total of $2M of funding over 4 rounds. Their latest funding round was raised on Jun 24, 2025 in the amount of $2M.
$1M
Priothera SAS's revenue is estimated to be in the range of $1M

Funding & Financials

$2M
Priothera SAS has raised a total of $2M of funding over 4 rounds. Their latest funding round was raised on Jun 24, 2025 in the amount of $2M.
$1M
Priothera SAS's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Priothera SAS

Amunix

Elicio Therapeutics

Magenta Therapeutics

Alector

LeonaBio

Synthekine

10x Genomics

AlloVir

Priothera SAS Tech Stack

Media & News

Priothera Limited receives financing of $2M in i-Nov funding.

bpifrance.com invests into Priothera Limited $2M in i-Nov funding.

Priothera Limited hired Hans Menssen as Board of Directors on Jun 3rd '25.

Priothera Limited hired Jens Hasskarl as Chief Medical Officer on May 6th '25.

EUROAPI UK Ltd partnered with Priothera Limited on Jun 18th '24.

Priothera Limited attends event 2024 American Society of Hematology (ASH) Annual Meeting.

Priothera Limited partnered with EIB on Feb 23rd '22.

Priothera SAS's Email Address Formats

Frequently Asked Questions

Where is Priothera SAS's headquarters located?

What is Priothera SAS's official website and social media links?

What is Priothera SAS's SIC code NAICS code?

How many employees does Priothera SAS have currently?

What industry does Priothera SAS belong to?

What technology does Priothera SAS use?

What is Priothera SAS's email format?

How much funding has Priothera SAS raised to date?

When was Priothera SAS founded?

Priothera SAS

Company Overview

Media & News

Priothera Limited receives financing of $2M in i-Nov funding.

bpifrance.com invests into Priothera Limited $2M in i-Nov funding.

Priothera Limited hired Hans Menssen as Board of Directors on Jun 3rd '25.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?